Income Statement Adaptimmune Therapeutics plc

Stocks

ADAP.Y

US00653A1079

Pharmaceuticals

Market Closed - OTC Markets 15:51:28 2026-06-04 EDT			5-day change	1st Jan Change
0.0278 ^USD	-7.64%		+3.70%	+7.69%

05-18	Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-17	Adaptimmune Therapeutics plc Announces CEO Changes	CI

c.YKMzi0wwdc6zuqudMOKKn0aNEJ6KPCe_nrYBwFqpiIA.Nelxuj5iQqbx9c7tA4vh2zf4I-zscl37zOllrWnG4vQC1VjRNHMiq_vb5g

Published financial data: ADAPTIMMUNE THERAPEUTICS PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	6.15M	27.15M	60.28M	178M	5.92M
Total Revenues	6.15M	27.15M	60.28M	178M	5.92M
Cost of Goods Sold, Total	111M	128M	127M	149M	-
Gross Profit	-105M	-101M	-66.23M	28.9M	5.92M
Selling General & Admin Expenses, Total	57.3M	61.09M	71.81M	81.31M	35.62M
R&D Expenses	-	-	-	-	48M
Other Operating Expenses	-	-	-	-	-13.56M
Other Operating Expenses, Total	57.3M	61.09M	71.81M	81.31M	70.05M
Operating Income	-162M	-162M	-138M	-52.41M	-64.12M
Interest Expense, Total	-	-	-	-3.35M	-7.27M
Interest And Investment Income	1.1M	1.54M	5.96M	6.6M	1.65M
Net Interest Expenses	1.1M	1.54M	5.96M	3.25M	-5.62M
Currency Exchange Gains (Loss)	3.85M	-536K	-807K	-1.73M	521K
Other Non Operating Income (Expenses)	-7K	-	-198K	-	-
EBT, Excl. Unusual Items	-157M	-161M	-133M	-50.89M	-69.22M
Restructuring Charges	-	-2.3M	-1.7M	-5.95M	-
Gain (Loss) On Sale Of Investments	6K	-	198K	-	-
Asset Writedown	-	-	-	-10.4M	-2.9M
In Process R&D Expenses	-	-	-	-	-5.89M
Other Unusual Items	-	-	22.05M	-	-
EBT, Incl. Unusual Items	-157M	-163M	-113M	-67.24M	-78.01M
Income Tax Expense	791K	2.5M	1.34M	3.58M	-
Earnings From Continuing Operations	-158M	-165M	-114M	-70.81M	-78.01M
Earnings Of Discontinued Operations	-	-	-	-	103M
Net Income to Company	-158M	-165M	-114M	-70.81M	25.21M
Net Income - (IS)	-158M	-165M	-114M	-70.81M	25.21M
Net Income to Common Incl Extra Items	-158M	-165M	-114M	-70.81M	25.21M
Net Income to Common Excl. Extra Items	-158M	-165M	-114M	-70.81M	-78.01M
Per Share Items
Net EPS - Basic	-1.01	-1.03	-0.57	-0.28	0.1
Basic EPS - Continuing Operations	-1.01	-1.03	-0.57	-0.28	-0.3
Basic Weighted Average Shares Outstanding	156M	161M	201M	252M	263M
Net EPS - Diluted	-1.01	-1.03	-0.57	-0.3	0.08
Diluted EPS - Continuing Operations	-1.01	-1.03	-0.57	-0.3	-0.3
Diluted Weighted Average Shares Outstanding	156M	161M	201M	252M	272M
Normalized Basic EPS	-0.63	-0.62	-0.41	-0.13	-0.16
Normalized Diluted EPS	-0.63	-0.62	-0.41	-0.13	-0.16
American Depositary Receipts Ratio (ADR)	6	6	6	6	6
Supplemental Items
EBITDA	-156M	-156M	-128M	-41.18M	-57.49M
EBITA	-161M	-161M	-138M	-52M	-63.97M
EBIT	-162M	-162M	-138M	-52.41M	-64.12M
EBITDAR	-151M	-151M	-121M	-34.32M	-57.47M
Total Revenues (As Reported)	6.15M	27.15M	60.28M	178M	-
Effective Tax Rate - (Ratio)	-0.5	-1.53	-1.19	-5.32	-
Current Domestic Taxes	-	-	26K	-	-
Current Foreign Taxes	791K	2.5M	1.31M	3.58M	-
Total Current Taxes	791K	2.5M	1.34M	3.58M	-
Normalized Net Income	-98.32M	-100M	-83.17M	-31.8M	-43.26M
Interest on Long-Term Debt	-	-	-	-	7.27M
Supplemental Operating Expense Items
General and Administrative Expenses	57.3M	61.09M	71.81M	-	-
Research And Development Expense From Footnotes	145M	158M	142M	161M	48M
Net Rental Expense, Total	4.68M	4.76M	6.74M	6.86M	25K
Imputed Operating Lease Interest Expense	-	-	-	3.7M	32.9K
Imputed Operating Lease Depreciation	-	-	-	3.17M	-7.9K
Stock-Based Comp., COGS (Total)	9.05M	6.26M	3.06M	3.88M	-
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	11.58M	11.98M	8.71M	-	-
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	8.18M	-
Stock-Based Comp., Other (Total)	-	-	-	-	-1.16M
Total Stock-Based Compensation	20.63M	18.24M	11.77M	12.05M	-1.16M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	150M	108M	144M	91.14M	25.95M
Short Term Investments	220M	96.57M	2.95M	60.47M	-
Total Cash And Short Term Investments	370M	205M	147M	152M	25.95M
Accounts Receivable, Total	752K	7.44M	821K	1.45M	6.99M
Other Receivables	33.26M	30.65M	46.1M	14.53M	3.48M
Total Receivables	34.01M	38.09M	46.92M	15.98M	10.47M
Inventory	746K	1.28M	1.33M	7.38M	-
Prepaid Expenses	9.04M	9.47M	9.95M	10.03M	2.91M
Other Current Assets, Total	2.08M	1.93M	2.41M	3.17M	5.98M
Total Current Assets	415M	255M	208M	188M	45.31M
Gross Property Plant And Equipment	87.62M	120M	131M	121M	46.04M
Accumulated Depreciation	-36.25M	-48.06M	-59.24M	-69.64M	-29.75M
Net Property Plant And Equipment	51.37M	71.54M	71.71M	51.22M	16.29M
Other Intangibles, Total	1M	442K	330K	3.88M	22K
Other Long-Term Assets, Total	1.72M	1.57M	3.03M	2.7M	1.73M
Total Assets	470M	329M	283M	246M	63.36M
Liabilities
Accounts Payable, Total	8.11M	4.75M	8.13M	8.69M	16.61M
Accrued Expenses, Total	29.58M	29.06M	28.85M	30.9M	-
Current Portion of Leases	2.32M	2.73M	5.38M	4.71M	4.93M
Current Income Taxes Payable	-	-	1.4M	-	-
Unearned Revenue Current, Total	22.2M	23.52M	28.97M	12.3M	-
Other Current Liabilities	327K	4.44M	51K	7.93M	696K
Total Current Liabilities	62.54M	64.5M	72.79M	64.53M	22.24M
Long-Term Debt	-	-	-	50.24M	-
Long-Term Leases	23.15M	20.35M	19.85M	19.26M	9.15M
Unearned Revenue Non Current	177M	161M	149M	95.82M	-
Other Non Current Liabilities	673K	1.3M	1.4M	4.27M	-
Total Liabilities	264M	247M	243M	234M	31.39M
Common Stock, Total	1.34M	1.4M	1.86M	2.08M	2.16M
Additional Paid In Capital	960M	991M	1.06B	1.11B	830M
Retained Earnings	-744M	-909M	-1.02B	-1.09B	-914M
Comprehensive Income and Other	-11.14M	-875K	-3.75M	-1.9M	114M
Total Common Equity	206M	81.88M	39.51M	11.85M	31.97M
Total Equity	206M	81.88M	39.51M	11.85M	31.97M
Total Liabilities And Equity	470M	329M	283M	246M	63.36M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	157M	165M	247M	257M	265M
ECS Total Common Shares Outstanding	156M	165M	227M	256M	265M
Book Value / Share	1.32	0.5	0.17	0.05	0.12
Tangible Book Value	205M	81.44M	39.18M	7.97M	31.95M
Tangible Book Value Per Share	1.31	0.49	0.17	0.03	0.12
Total Debt	25.47M	23.08M	25.24M	74.21M	14.08M
Net Debt	-344M	-182M	-122M	-77.4M	-11.87M
Debt Equivalent Oper. Leases	37.42M	38.05M	53.96M	54.91M	200K
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	746K	1.28M	1.33M	7.3M	-
Inventories - Work In Process, Total	-	-	-	84K	-
Machinery, Total	32.65M	34.92M	38.97M	39.91M	865K
Full Time Employees	494	534	449	506	272

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-158M	-165M	-114M	-70.81M	25.21M
Depreciation & Amortization - CF	5.63M	5.27M	9.45M	10.81M	11.13M
Amortization of Goodwill and Intangible Assets - (CF)	937K	809K	387K	411K	155K
Depreciation & Amortization, Total	6.57M	6.08M	9.84M	11.22M	11.28M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	22K
(Gain) Loss From Sale Of Asset	-	-	-	-	-142M
(Gain) Loss on Sale of Investments - (CF)	5.28M	2.52M	-1.99M	-1.27M	-
Asset Writedown & Restructuring Costs	-	-	-	10.4M	10.15M
Stock-Based Compensation (CF)	20.63M	18.24M	11.77M	12.05M	-1.16M
Other Operating Activities, Total	1.71M	-1.62M	-21.68M	2.18M	9.1M
Change In Accounts Receivable	-19.36M	-9.81M	-1.29M	29.76M	-14.03M
Change In Inventories	-	-	-	-7.36M	-3.68M
Change In Accounts Payable	4.21M	4.41M	-9.09M	9.62M	-9.54M
Change in Unearned Revenues	150M	3.87M	-14.57M	-69.8M	-6.68M
Change in Other Net Operating Assets	-	-	-	787K	-156K
Cash from Operations	10.73M	-142M	-141M	-73.21M	-122M
Capital Expenditure	-8.57M	-29.5M	-4.68M	-886K	-388K
Sale of Property, Plant, and Equipment	-	-	-	-	50.58M
Cash Acquisitions	-	-	45.26M	-	-
Sale (Purchase) of Intangible assets	-207K	-244K	-199K	-1.83M	-
Investment in Marketable and Equity Securities, Total	84.58M	119M	135M	-56.36M	60.86M
Other Investing Activities, Total	-	-	1.12M	129K	220K
Cash from Investing	75.8M	89.14M	177M	-58.95M	111M
Long-Term Debt Issued, Total	-	-	-	49.5M	-
Total Debt Issued	-	-	-	49.5M	-
Long-Term Debt Repaid, Total	-	-	-	-	-55.56M
Total Debt Repaid	-	-	-	-	-55.56M
Issuance of Common Stock	3.29M	12.87M	880K	29.25M	1.84M
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	3.29M	12.87M	880K	78.75M	-53.72M
Foreign Exchange Rate Adjustments	365K	-2.3M	877K	-402K	-831K
Net Change in Cash	90.18M	-42.06M	37.42M	-53.81M	-65.19M
Supplemental Items
Cash Interest Paid	-	-	-	2.09M	8.81M
Cash Income Tax Paid (Refund)	535K	630K	4M	1.52M	-12.57M
Levered Free Cash Flow	-75.01M	-110M	-73.76M	2.17M	-61.61M
Unlevered Free Cash Flow	-75.01M	-110M	-73.76M	4.26M	-57.07M
Change In Net Working Capital	-7.98M	3.34M	4.22M	-16.46M	26.75M
Net Debt Issued / Repaid	-	-	-	49.5M	-55.56M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-22.03	-25.31	-28.22	-12.39	-25.87
Return on Total Capital	-34.01	-60.08	-101.68	-43.44	-60.09
Return On Equity %	-57.78	-114.96	-187.61	-275.74	-346.65
Return on Common Equity	-57.78	-114.96	-187.61	-275.74	-346.65
Margin Analysis
Gross Profit Margin %	-1.71K	-370.48	-109.87	16.23	100
SG&A Margin	931.94	225.03	119.13	45.67	601.22
EBITDA Margin %	-2.53K	-573.13	-212.67	-23.13	-970.48
EBITA Margin %	-2.62K	-592.53	-228.35	-29.21	-1.08K
EBIT Margin %	-2.64K	-595.51	-228.99	-29.44	-1.08K
Income From Continuing Operations Margin %	-2.57K	-609.46	-188.9	-39.78	-1.32K
Net Income Margin %	-2.57K	-609.46	-188.9	-39.78	425.49
Net Avail. For Common Margin %	-2.57K	-609.46	-188.9	-39.78	-1.32K
Normalized Net Income Margin	-1.6K	-369.88	-137.98	-17.86	-730.3
Levered Free Cash Flow Margin	-1.22K	-404.46	-122.36	1.22	-1.04K
Unlevered Free Cash Flow Margin	-1.22K	-404.46	-122.36	2.4	-963.39
Asset Turnover
Asset Turnover	0.01	0.07	0.2	0.67	0.04
Fixed Assets Turnover	0.13	0.44	0.84	2.9	0.18
Receivables Turnover (Average Receivables)	13.8	6.63	14.6	156.51	1.4
Inventory Turnover (Average Inventory)	78.45	126.15	97.02	34.25	-
Short Term Liquidity
Current Ratio	6.64	3.96	2.85	2.92	2.04
Quick Ratio	6.45	3.76	2.66	2.6	1.64
Operating Cash Flow to Current Liabilities	0.17	-2.2	-1.94	-1.13	-5.48
Days Sales Outstanding (Average Receivables)	26.44	55.04	24.99	2.34	260.13
Days Outstanding Inventory (Average Inventory)	4.65	2.89	3.76	10.69	-
Average Days Payable Outstanding	24.11	18.31	18.57	19.84	-
Cash Conversion Cycle (Average Days)	6.98	39.62	10.18	-6.81	-
Long Term Solvency
Total Debt/Equity	12.37	28.18	63.86	626.29	44.05
Total Debt / Total Capital	11	21.99	38.97	86.23	30.58
LT Debt/Equity	11.24	24.85	50.24	586.55	28.63
Long-Term Debt / Total Capital	10	19.39	30.66	80.76	19.87
Total Liabilities / Total Assets	56.14	75.11	86.02	95.18	49.54
EBIT / Interest Expense	-	-	-	-15.65	-8.82
EBITDA / Interest Expense	-	-	-	-10.25	-7.27
(EBITDA - Capex) / Interest Expense	-	-	-	-10.52	-7.32
Total Debt / EBITDA	-0.17	-0.15	-0.21	-2.16	-0.27
Net Debt / EBITDA	2.28	1.2	1	2.26	0.22
Total Debt / (EBITDA - Capex)	-0.16	-0.13	-0.2	-2.11	-0.26
Net Debt / (EBITDA - Capex)	2.16	1.01	0.96	2.2	0.22
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	55.36	341.5	122.05	195.34	-
Gross Profit, 1 Yr. Growth %	19.78	-4.16	-34.15	-143.64	-
EBITDA, 1 Yr. Growth %	23.74	-0.06	-17.61	-65.92	-64.43
EBITA, 1 Yr. Growth %	21.8	-0.28	-14.43	-60.1	-62.9
EBIT, 1 Yr. Growth %	21.62	-0.36	-14.62	-59.9	-62.84
Earnings From Cont. Operations, 1 Yr. Growth %	21.52	4.66	-31.18	-37.81	-55.9
Net Income, 1 Yr. Growth %	21.52	4.66	-31.18	-37.81	-135.07
Normalized Net Income, 1 Yr. Growth %	20.99	2.13	-17.17	-59.46	-59.88
Diluted EPS Before Extra, 1 Yr. Growth %	11.12	1.15	-44.82	-47.03	-58.33
Accounts Receivable, 1 Yr. Growth %	441.01	888.7	-88.96	77.1	380.74
Inventory, 1 Yr. Growth %	-64.24	71.45	3.91	455.23	-
Net Property, Plant and Equip., 1 Yr. Growth %	10.1	39.26	0.24	-28.57	-66.61
Total Assets, 1 Yr. Growth %	4.08	-29.95	-14.08	-12.97	-74.29
Tangible Book Value, 1 Yr. Growth %	-39.63	-60.27	-51.88	-79.66	607.57
Common Equity, 1 Yr. Growth %	-39.64	-60.25	-51.74	-70.01	145.24
Cash From Operations, 1 Yr. Growth %	-120.02	-1.42K	-0.63	-48.04	76.38
Capital Expenditures, 1 Yr. Growth %	266.25	244.02	-84.13	-81.07	-56.21
Levered Free Cash Flow, 1 Yr. Growth %	19.42	46.38	-32.83	-103.14	-10.74
Unlevered Free Cash Flow, 1 Yr. Growth %	19.42	46.38	-32.83	-106.17	-12.09
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	134.1	161.9	213.1	156.08	-68.65
Gross Profit, 2 Yr. CAGR %	4.35	7.15	-20.56	-46.39	-70.09
EBITDA, 2 Yr. CAGR %	8.7	11.21	-9.25	-48.93	-31.03
EBITA, 2 Yr. CAGR %	7.75	10.21	-7.62	-43.55	-29.94
EBIT, 2 Yr. CAGR %	7.74	10.08	-7.76	-43.46	-29.95
Earnings From Cont. Operations, 2 Yr. CAGR %	7.36	12.78	-15.13	-34.58	-17.23
Net Income, 2 Yr. CAGR %	7.36	12.78	-15.13	-34.58	-52.95
Normalized Net Income, 2 Yr. CAGR %	7.18	11.16	-8.02	-44.12	-25.74
Diluted EPS Before Extra, 2 Yr. CAGR %	-11.88	6.02	-25.49	-45.94	-27.22
Accounts Receivable, 2 Yr. CAGR %	-	631.36	4.49	-55.78	191.79
Inventory, 2 Yr. CAGR %	-28.49	-21.7	33.47	140.19	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.47	23.82	18.15	-15.38	-52.33
Total Assets, 2 Yr. CAGR %	60.82	-14.61	-22.42	-13.52	-52.65
Tangible Book Value, 2 Yr. CAGR %	29.91	-51.02	-56.28	-68.72	-9.7
Common Equity, 2 Yr. CAGR %	29.07	-51.02	-56.2	-61.96	-10.05
Cash From Operations, 2 Yr. CAGR %	-69.12	62.65	262.36	-28.14	-6.98
Capital Expenditures, 2 Yr. CAGR %	132.07	254.96	-26.11	-82.67	-71.21
Levered Free Cash Flow, 2 Yr. CAGR %	4.31	32.22	-0.84	-86.03	-5.62
Unlevered Free Cash Flow, 2 Yr. CAGR %	4.31	32.22	-0.84	-80.42	-9.16
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-53.07	189.23	147.88	207.07	-39.8
Gross Profit, 3 Yr. CAGR %	39.37	1.43	-8.9	-34.94	-61.09
EBITDA, 3 Yr. CAGR %	27.82	5.7	0.63	-35.81	-28.59
EBITA, 3 Yr. CAGR %	25.43	5.01	1.3	-31.43	-26.81
EBIT, 3 Yr. CAGR %	25.36	4.97	1.14	-31.39	-26.87
Earnings From Cont. Operations, 3 Yr. CAGR %	18.29	6.45	-4.34	-23.49	-22.17
Net Income, 3 Yr. CAGR %	18.29	6.45	-4.34	-23.49	-46.59
Normalized Net Income, 3 Yr. CAGR %	19.34	5.47	0.78	-31.35	-24.83
Diluted EPS Before Extra, 3 Yr. CAGR %	1.14	-7.74	-14.72	-33.5	-33.63
Accounts Receivable, 3 Yr. CAGR %	57.63	-	80.76	24.58	-2.04
Inventory, 3 Yr. CAGR %	-11.79	-4.29	-13.95	114.66	-
Net Property, Plant and Equip., 3 Yr. CAGR %	12.46	11.32	15.4	-0.1	-38.93
Total Assets, 3 Yr. CAGR %	19.27	21.91	-14.44	-19.39	-42.25
Tangible Book Value, 3 Yr. CAGR %	-5.83	-12.47	-51.31	-66.12	-26.8
Common Equity, 3 Yr. CAGR %	-5.86	-12.84	-51.26	-61.4	-26.91
Cash From Operations, 3 Yr. CAGR %	-53.16	8.01	38.01	89.67	-4.91
Capital Expenditures, 3 Yr. CAGR %	29.92	164.61	25.98	-53.07	-76.39
Levered Free Cash Flow, 3 Yr. CAGR %	-4.49	16.78	5.5	-69.29	-17.88
Unlevered Free Cash Flow, 3 Yr. CAGR %	-4.49	16.78	5.5	-61.55	-19.95
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-15.41	-6.42	0.26	175.49	8.4
Gross Profit, 5 Yr. CAGR %	16.17	15.21	11.31	-21.41	-41.65
EBITDA, 5 Yr. CAGR %	17.5	15.64	11.45	-20.75	-14.5
EBITA, 5 Yr. CAGR %	17.3	14.92	10.99	-17.84	-13.55
EBIT, 5 Yr. CAGR %	17.38	14.92	10.88	-17.81	-13.63
Earnings From Cont. Operations, 5 Yr. CAGR %	17.17	18.73	3.58	-12.39	-9.72
Net Income, 5 Yr. CAGR %	17.17	18.73	3.58	-12.39	-27.98
Normalized Net Income, 5 Yr. CAGR %	17.35	18.4	7.54	-17.96	-11.85
Diluted EPS Before Extra, 5 Yr. CAGR %	0.07	5.17	-10.4	-25.49	-19.96
Accounts Receivable, 5 Yr. CAGR %	-12.66	104.87	33.72	-	118.92
Inventory, 5 Yr. CAGR %	-8.95	-19.4	4.1	38.29	-
Net Property, Plant and Equip., 5 Yr. CAGR %	12.99	11.95	14.7	-0.25	-18.98
Total Assets, 5 Yr. CAGR %	14.9	3.19	0.42	6.26	-32.47
Tangible Book Value, 5 Yr. CAGR %	4.45	-16.58	-30.71	-42	-37.67
Common Equity, 5 Yr. CAGR %	4.39	-16.6	-30.68	-37.44	-37.72
Cash From Operations, 5 Yr. CAGR %	-25.94	21.15	6.18	-8.24	17.87
Capital Expenditures, 5 Yr. CAGR %	-5.71	3.66	3.66	-11.06	-30.2
Levered Free Cash Flow, 5 Yr. CAGR %	15.24	30.16	-3.04	-49.92	-0.38
Unlevered Free Cash Flow, 5 Yr. CAGR %	15.24	30.16	-3.04	-42.68	-1.9